Page last updated: 2024-12-08

carboxytolbutamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

carboxytolbutamide: metabolite of tolbutamide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159651
CHEBI ID165189
SCHEMBL ID1478625
MeSH IDM0049760

Synonyms (33)

Synonym
NCGC00165936-01
carboxytolbutamide
4-(butylcarbamoylsulamoyl)benzoic acid
2224-10-4
CHEBI:165189
FT-0664372
4-(butylcarbamoylsulfamoyl)benzoic acid
SCHEMBL1478625
4-(((butylamino)carbonyl)amino)sulfonylbenzoic acid
n-(4-carboxybenzenesulfonyl)-n-butylurea
tolbutamide carboxylic acid
jgr4fm80vy ,
1-butyl-3-(4-carboxyphenyl)sulfonylurea
unii-jgr4fm80vy
carboxycarbutamide
1-butyl-3-(p-carboxyphenyl)sulfonylurea
4-carboxy tolbutamide
4-[[[(butylamino)carbonyl]amino]sulfonyl]-benzoic acid
AKOS008132335
n-butyl-n''-(4-carboxyphenylsulfonyl)urea
GCMVATDSSHTCOS-UHFFFAOYSA-N
benzoic acid, 4-((((butylamino)carbonyl)amino)sulfonyl)-
mfcd00272697
DTXSID10176780
4-{[(butyl-c-hydroxycarbonimidoyl)amino]sulfonyl}benzoic acid
J-014603
4-(n-(butylcarbamoyl)sulfamoyl)benzoic acid
BS-16644
Q27281500
D81827
p-[(butylcarbamoyl)sulfamoyl]-benzoic acid;tolbutamide carboxylic acid
4-{[(butylcarbamoyl)amino]sulfonyl}benzoic acid
Z425552398

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Noncompartmental pharmacokinetic parameters were calculated using standard equations and compared with those previously reported in Caucasian subjects using the Mann-Whitney U test."( Pharmacokinetics of tolbutamide in ethnic Chinese.
Bridge, S; Gross, AS; Shenfield, GM, 1999
)
0.3

Dosage Studied

ExcerptRelevanceReference
" Insulin secretory dose-response curves utilizing static incubations fit a single binding site model and established that glyburide (ED50 = 112 +/- 18 nM) is a more potent secretagogue than tolbutamide (ED50 = 15 +/- 3 microM)."( Increased cytosolic calcium. A signal for sulfonylurea-stimulated insulin release from beta cells.
Berg, M; Boyd, AE; Gaines, KL; Nelson, TY; Rajan, AS, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sulfonamideAn amide of a sulfonic acid RS(=O)2NR'2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (50.00)18.7374
1990's7 (35.00)18.2507
2000's3 (15.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.91 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (8.70%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (91.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]